Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End user (Pharma & CROs) & Region - Global Forecast to 2030
... due to increasing adoption of drug discovery, as the adoption increases the demand for these services rises. Additionally, increasing government support to provide grants for healthcare is increasing, thus rising the number of clinical trials, ... Read More
-
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030
... as pharmaceutical, biotechnology, and medical device companies are increasingly outsourcing their clinical research activities to Contract Research Organizations (CROs). Flexible service models, such as Functional Service Provider (FSP) and hybrid service delivery models, offered by ... Read More
-
Global Pompe Disease Treatment Market - 2025-2033
... disease, also known as Glycogen Storage Disease Type II (GSDII) or Acid Maltase Deficiency, is a rare, inherited, and progressive metabolic disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). This enzyme is ... Read More
-
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
... compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and ... Read More
-
CRO Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... Biopharmaceutical companies' increased R&D activities are poised to drive industry growth during the forecast period. With heightened R&D funding, these companies are intensifying their drug discovery endeavors, targeting chronic diseases such as cancer and cardiovascular ... Read More
-
Cognitive Assessment And Training Global Market Report 2025
... and training market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Regulatory Affairs Outsourcing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2025
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Janus Kinase ... Read More
-
Clinical Trial Supplies Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
In Silico Clinical Trials Global Market Report 2025
... clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Pediatric Clinical Trials Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Global Virtual Clinical Trials Market - 2025-2033
... trials refer to clinical studies that are conducted remotely, leveraging digital technologies to collect data, monitor patients and manage trial procedures without the need for participants to visit a physical clinical site. These trials, also ... Read More
-
Systemic Antifungals Market Size, Share, By Drug Classes (Azoles, Echinocandins, Polyenes, and Others), Indication (Aspergillosis, Histoplasmosis, Gastrointestinal Candidiasis, Blastomycosis, Fungal Endocarditis, and Others), End-Users (Hospital & Specialty Clinics, Ambulatory Surgical Centers, Research Institute & Clinical Trial Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035
... share, by top players, by type, by the end user, and by region. Systemic Antifungals Market Size Statistics Till 2035, the market is envisioned to flourish at USD 36.8 Billion. The systemic antifungals market size ... Read More
-
Top 6 Growth Opportunities in Pharma-Biotech, 2025
... and drug approvals, as breakthrough treatments, particularly in personalized medicine, promise to revolutionize patient care. Oncology will remain the most valuable therapy area, while the immunomodulator segment will grow through existing blockbuster sales, and obesity ... Read More
-
Top 10 Strategic Imperatives in the Life Sciences Industry, 2025
... behind the transformation, including potential, challenges, and drivers. This analysis explores the strategic imperatives shaping and transforming the life sciences industry. They are as follows: SaaS evolution provides adaptive intelligence for laboratories CDMOs augment competencies ... Read More
-
Global Clinical Trials Market - 2022-2029
... a CAGR of 7.4% during the forecast period (2024-2031). The clinical trials market is an essential part of the healthcare industry that involves conducting clinical studies to evaluate the safety and efficacy of new drugs, ... Read More
-
Clinical Trials Market in US 2025-2029
... the clinical trials market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Life Science Analytics Market Size, Trends, by Type (Predictive, Descriptive, Perspective), By Application (Sales & Marketing, Regulatory Compliance, R&D, Pharma Covigilance), and By Component (Software, Services), by Delivery (On-Premises, On-Demand), By End User (Medical Devices Companies, Research Centres, Third Party Administrations): Global Opportunity Analysis and Industry Forecast, 2023-2030.
... Devices Companies, Research Centres, Third Party Administrations): Global Opportunity Analysis and Industry Forecast, 2023-2030. Global Life Science Analytics Market Global Life Science Analytics Market was valued at US$ 27.1 Bn in 2022, estimated to reach ... Read More
-
Regulatory Affairs Outsourcing
... at a CAGR of 8.5% over the analysis period 2024-2030. Regulatory Submissions End-Use, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.7 Billion by the end ... Read More
-
Electronic Data Capture
... at a CAGR of 13.6% over the analysis period 2024-2030. EDC Services, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$1.4 Billion by the end of ... Read More
-
e-Clinical Trial Technologies
... at a CAGR of 13.1% over the analysis period 2024-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$9.9 Billion by ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.8 Billion ... Read More
-
Preclinical Contract Research Organizations
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Toxicology Testing Service, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$3.2 Billion by ... Read More
-
Clinical Trial Supplies
... at a CAGR of 4.7% over the analysis period 2024-2030. Phase I Clinical Trial Supplies, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$532.1 Million by ... Read More
-
Healthcare Contract Research Organization (CRO)
... Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Clinical CRO, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$68.2 Billion ... Read More
Research Assistance
